IL10 and primary central nervous system lymphoma: Several biomarkers have been investigated in PCNSL, including cytokine IL-10, which is overexpressed in tumor tissue and detected in the CSF of patients and is associated with the immunosuppressive microenvironment of the tumor, potentially serving as a diagnostic and prognostic biomarker (25).